It's What's Inside That MattersEdwards Lifesciences Annual Report
Consolidated Statements of Cash Flows
Our complete financial results and consolidated financial statements include the notes referred to below, appear in our Annual Report on Form 10-K as filed with the Securities and Exchange Commission for the year ended December 31, 2006. Download a copy of our Form-10-K.
Twelve months ended December 31, (in millions) 2006 2005 2004

Cash flows from operating activities      
  Net income $ 130.5 $ 79.3 $ 1.7
   Adjustments to reconcile net income to cash provided
   by operating activities:
     
     Depreciation and amortization 56.8 56.2 55.7
     Stock-based compensation (Notes 2 and 12) 26.6 3.3
     Deferred income taxes 7.1 (13.8) 0.8
     Purchased in process research and development 1.2 93.3
     Special charges (gains), net 19.3 (0.8) 19.6
     Other 5.4 15.0 6.7
  Changes in operating assests and liabilities:      
     Accounts and other receivables 2.5 (12.6) 7.1
     Accounts receivable securitzation 0.9 (2.6) 2.5
     Inventories (12.8) (12.9) (7.1)
     Accounts payable and accrued liabilities (3.9) 25.1 13.0
     Prepaid expenses (1.2) 0.3 (7.2)
     Other (0.4) (0.9) (5.5)

       Net cash provided by operating activities 230.8 136.8 180.6

  Cash flows from investing activities      
  Capital expenditures (57.4) (48.5) (42.5)
  Investments in intangible assets (2.0) (2.5) (11.0)
  Investments in unconsolidated affliates (1.8) (1.5) (1.0)
  Proceeds from sale of assets (Note 4) 22.2 24.6 15.1
  Acquisitions (137.7)
  Other 3.3 0.7

       Net cash used in investing activities (35.7) (27.2) (177.1)

  Cash flows from financing activities      
  Proceeds from issuance of long-term debt 54.8 337.3 285.7
  Payments on long-term debt (140.7) (278.2) (278.6)
  Purchases of treasury stock (145.9) (53.5) (59.1)
  Proceeds from stock plans 33.5 26.2 30.5
  Excess tax benefit from stock plans (Notes 2 and 12) 5.2
  Other (0.5) (2.8) 1.0

       Net cash (used in) provided by financing activities (193.6) 29.0 (20.5)

Effect of currency exchange rate changes on cash and cash equivalents 2.7 (8.9) 4.8

       Net increase (decrease) in cash and cash equivalents 4.2 129.7 (12.2)
Cash and cash equivalents at beginning of year 178.6 48.9 61.1

Cash and cash equivalents at end of year $ 182.8 $ 178.6 $ 48.9

Supplemental disclosures:      
Cash paid during the year for:      
  Interest $ 10.5 $ 12.3 $ 12.9
  Income taxes $ 14.3 $ 37.2 $ 11.4
Non-cash transactions:      

  Investment received in exchange for assests
  (Notes 4 and 8)

$ 6.4